Pre-Diabetes — Full-fat Yogurt and Glucose Tolerance
Citation(s)
Andoh A, Fujiyama Y, Hata K, Araki Y, Takaya H, Shimada M, Bamba T Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells. Clin Exp Immunol. 1999 Oct;118(1):23-9.
Bainbridge ML, Cersosimo LM, Wright AD, Kraft J Content and Composition of Branched-Chain Fatty Acids in Bovine Milk Are Affected by Lactation Stage and Breed of Dairy Cow. PLoS One. 2016 Mar 1;11(3):e0150386. doi: 10.1371/journal.pone.0150386. eCollection 2016.
Barbaresko J, Koch M, Schulze MB, Nöthlings U Dietary pattern analysis and biomarkers of low-grade inflammation: a systematic literature review. Nutr Rev. 2013 Aug;71(8):511-27. doi: 10.1111/nure.12035. Epub 2013 Jun 13. Review.
Bohl M, Bjørnshave A, Gregersen S, Hermansen K Whey and Casein Proteins and Medium-Chain Saturated Fatty Acids from Milk Do Not Increase Low-Grade Inflammation in Abdominally Obese Adults. Rev Diabet Stud. 2016 Summer-Fall;13(2-3):148-157. Epub 2016 Mar 14.
Caesar R, Nygren H, Orešic M, Bäckhed F Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism. J Lipid Res. 2016 Mar;57(3):474-81. doi: 10.1194/jlr.M065847. Epub 2016 Jan 18.
Calder PC Dietary modification of inflammation with lipids. Proc Nutr Soc. 2002 Aug;61(3):345-58. Review.
Calder PC Fatty acids and inflammation: the cutting edge between food and pharma. Eur J Pharmacol. 2011 Sep;668 Suppl 1:S50-8. doi: 10.1016/j.ejphar.2011.05.085. Epub 2011 Jul 28. Review.
Cani PD, Osto M, Geurts L, Everard A Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes. 2012 Jul-Aug;3(4):279-88. Epub 2012 May 14. Review.
Carrillo C, Cavia Mdel M, Alonso-Torre S Role of oleic acid in immune system; mechanism of action; a review. Nutr Hosp. 2012 Jul-Aug;27(4):978-90. doi: 10.3305/nh.2012.27.4.5783. Review.
Hammond RA, Levine R The economic impact of obesity in the United States. Diabetes Metab Syndr Obes. 2010 Aug 30;3:285-95. doi: 10.2147/DMSOTT.S7384.
Holmberg S, Thelin A High dairy fat intake related to less central obesity: a male cohort study with 12 years' follow-up. Scand J Prim Health Care. 2013 Jun;31(2):89-94. doi: 10.3109/02813432.2012.757070. Epub 2013 Jan 15.
Huebner SM, Olson JM, Campbell JP, Bishop JW, Crump PM, Cook ME Low Dietary c9t11-Conjugated Linoleic Acid Intake from Dairy Fat or Supplements Reduces Inflammation in Collagen-Induced Arthritis. Lipids. 2016 Jul;51(7):807-19. doi: 10.1007/s11745-016-4163-8. Epub 2016 Jun 7.
Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome. Nature. 2012 Jun 13;486(7402):207-14. doi: 10.1038/nature11234.
Jenkins B, West JA, Koulman A A review of odd-chain fatty acid metabolism and the role of pentadecanoic Acid (c15:0) and heptadecanoic Acid (c17:0) in health and disease. Molecules. 2015 Jan 30;20(2):2425-44. doi: 10.3390/molecules20022425. Review.
Jensen RG The composition of bovine milk lipids: January 1995 to December 2000. J Dairy Sci. 2002 Feb;85(2):295-350. Review.
Keeney, M K., Katz, I. & Allison, M.J. On the probable origin of some milk fat acids in rumen microbial lipids. J Am Oil Chem Soc 39, 198-201 (1962).
Kratz M, Baars T, Guyenet S The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr. 2013 Feb;52(1):1-24. doi: 10.1007/s00394-012-0418-1. Epub 2012 Jul 19. Review.
Labonté MÈ, Couture P, Richard C, Desroches S, Lamarche B Impact of dairy products on biomarkers of inflammation: a systematic review of randomized controlled nutritional intervention studies in overweight and obese adults. Am J Clin Nutr. 2013 Apr;97(4):706-17. doi: 10.3945/ajcn.112.052217. Epub 2013 Feb 27. Review.
Lallès JP Dairy products and the French paradox: Could alkaline phosphatases play a role? Med Hypotheses. 2016 Jul;92:7-11. doi: 10.1016/j.mehy.2016.04.033. Epub 2016 Apr 20.
Li, S , Field, A., Rimm, E. & Flint, A. Dairy consumption with onset of overweight and obesity among U.S. adolescents. FASEB J 28, 370.7 (2014).
Mai V, Draganov PV Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. World J Gastroenterol. 2009 Jan 7;15(1):81-5. Review.
Misiak B, Leszek J, Kiejna A Metabolic syndrome, mild cognitive impairment and Alzheimer's disease--the emerging role of systemic low-grade inflammation and adiposity. Brain Res Bull. 2012 Nov 1;89(3-4):144-9. doi: 10.1016/j.brainresbull.2012.08.003. Epub 2012 Aug 18. Review.
Moreno-Indias I, Cardona F, Tinahones FJ, Queipo-Ortuño MI Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol. 2014 Apr 29;5:190. doi: 10.3389/fmicb.2014.00190. eCollection 2014. Review.
O'Neill S, O'Driscoll L Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015 Jan;16(1):1-12. doi: 10.1111/obr.12229. Epub 2014 Nov 18. Review.
Poynter ME, Daynes RA Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem. 1998 Dec 4;273(49):32833-41.
Reifen R, Karlinsky A, Stark AH, Berkovich Z, Nyska A a-Linolenic acid (ALA) is an anti-inflammatory agent in inflammatory bowel disease. J Nutr Biochem. 2015 Dec;26(12):1632-40. doi: 10.1016/j.jnutbio.2015.08.006. Epub 2015 Aug 14.
Ren J, Chung SH Anti-inflammatory effect of alpha-linolenic acid and its mode of action through the inhibition of nitric oxide production and inducible nitric oxide synthase gene expression via NF-kappaB and mitogen-activated protein kinase pathways. J Agric Food Chem. 2007 Jun 27;55(13):5073-80. Epub 2007 Jun 2.
Reynolds CM, Roche HM Conjugated linoleic acid and inflammatory cell signalling. Prostaglandins Leukot Essent Fatty Acids. 2010 Apr-Jun;82(4-6):199-204. doi: 10.1016/j.plefa.2010.02.021. Epub 2010 Mar 7. Review.
Scharf RJ, Demmer RT, DeBoer MD Longitudinal evaluation of milk type consumed and weight status in preschoolers. Arch Dis Child. 2013 May;98(5):335-40. doi: 10.1136/archdischild-2012-302941. Epub 2013 Mar 18.
Vassiliou EK, Gonzalez A, Garcia C, Tadros JH, Chakraborty G, Toney JH Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-alpha both in vitro and in vivo systems. Lipids Health Dis. 2009 Jun 26;8:25. doi: 10.1186/1476-511X-8-25.
Viladomiu M, Hontecillas R, Bassaganya-Riera J Modulation of inflammation and immunity by dietary conjugated linoleic acid. Eur J Pharmacol. 2016 Aug 15;785:87-95. doi: 10.1016/j.ejphar.2015.03.095. Epub 2015 May 15. Review.
Vinolo MA, Rodrigues HG, Nachbar RT, Curi R Regulation of inflammation by short chain fatty acids. Nutrients. 2011 Oct;3(10):858-76. doi: 10.3390/nu3100858. Epub 2011 Oct 14. Review.
Vitale G, Salvioli S, Franceschi C Oxidative stress and the ageing endocrine system. Nat Rev Endocrinol. 2013 Apr;9(4):228-40. doi: 10.1038/nrendo.2013.29. Epub 2013 Feb 26. Review.
Walsh, H H., H.; Cersosimo, L.; Kien, C.L.; Kraft, J. Decreased abundance of firmicutes in the gut microbiota after consumption of a diet containing milk fats. FASEB J 30, 683.611 (2016).
Yakoob MY, Shi P, Willett WC, Rexrode KM, Campos H, Orav EJ, Hu FB, Mozaffarian D Circulating Biomarkers of Dairy Fat and Risk of Incident Diabetes Mellitus Among Men and Women in the United States in Two Large Prospective Cohorts. Circulation. 2016 Apr 26;133(17):1645-54. doi: 10.1161/CIRCULATIONAHA.115.018410. Epub 2016 Mar 22.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.